Minnesota 2025-2026 Regular Session

Minnesota House Bill HF2426

Introduced
3/17/25  

Caption

Plant canopy that medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.

Impact

The legislation is expected to have a significant impact on the medical cannabis industry in Minnesota. Supporting the increase in cultivation area is an acknowledgment of the rising demand for medical cannabis. Businesses may be better able to supply the medical market while also exploring possibilities within the adult-use market. Additionally, the bill establishes an annual verification and authorization procedure for businesses seeking to cultivate cannabis for sale, ensuring compliance and fostering accountability within the industry.

Summary

House File 2426 aims to increase the plant canopy that a medical cannabis combination business can use to cultivate cannabis intended for sale as medical cannabis flower or medical cannabinoid products. Specifically, the bill amends Minnesota Statutes to allow these businesses to cultivate cannabis in an area of up to 90,000 square feet, up from a previous limit of 60,000 square feet. This provision is aimed at expanding the capacity of licensed cannabis businesses to meet the growing demand for medical cannabis products in the state.

Contention

Notably, there may be points of contention regarding the expansion of cultivation areas. Opponents may argue that increasing the plant canopy could lead to potential oversaturation in the market or raise concerns about quality control. Furthermore, issues of regulation and oversight for such a substantial increase in cultivation space could lead to debates regarding the state's capability to manage these changes effectively and ensure that businesses adhere to established regulations.

Companion Bills

MN SF2165

Similar To Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision

Similar Bills

MN HF1254

Manufacture of certain products for sale outside of Minnesota provided, tetrahydrocannabivarin designated as a nonintoxicating cannabinoid, potency limits modified, social equity ownership requirements lowered to 51 percent, manufacturing limits established, and cannabis cultivator license authorizations clarified.

MN SF781

Cannabis regulation authorization and appropriation

MN SF2370

Omnibus Cannabis Policy Bill

MN HF773

Regulation of concentration and conversion of cannabinoids derived from hemp provided, regulation of cannabinoid transportation and testing provided, licensing of manufacturers and distributors provided, cannabis product regulations provided, enforcement of regulations provided, licensing guidelines established, gross receipts tax established, criminal penalties established, exclusive liquor stores authorized to sell products, and money appropriated.

MN HF1615

Cannabis policy bill.

MN HF4757

Cannabis; Office of Cannabis Management and the Department of Health appropriations modified, cannabis provisions modified, Department of Commerce assessed fees modified, consumer protection provisions added and modified, Minnesota Consumer Data Privacy Act established, rulemaking authorized, data classified, technical changes made, reports required, and money appropriated.

MN SF73

Cannabis provisions modification

MN HF100

Cannabis finance and policy bill.